相关实验视频

Updated: Jun 25, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

紧密刺激通过抑制Th17细胞透来抑制自身免疫性脑膜炎

Kayleigh Peters¹, Trisha McDonald¹, Fauziyya Muhammad²

¹Department of Ophthalmology/Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, 608 Stanton L Young Blvd, Oklahoma City, OK 73104, United States.

Journal of leukocyte biology

|May 24, 2024

概括

刺激T细胞免疫球蛋白和ITIM域 (TIGIT) 激动剂可以治疗眼部自身免疫性疾病. TIGIT疗法降低了实验性自身免疫性脑膜炎的严重程度,并诱导调节性T细胞产生持久的耐药性.

科学领域:

免疫学免疫学免疫学
眼科医生眼科眼科
自免疫性疾病自免疫性疾病

背景情况:

T细胞免疫球蛋白和ITIM域 (TIGIT) 是一种抑制T细胞激活的免疫检查点分子.
TIGIT在促进免疫抑制环境方面发挥着作用,对自身免疫性疾病有潜在的益处.
在眼部自身免疫性疾病中,TIGIT激动剂的治疗潜力仍然未被探索.

研究的目的:

调查T辅助细胞17 (Th17) 和调控性T细胞 (Tregs) 上的TIGIT表达.
确定TIGIT在实验性自身免疫性脑膜炎 (EAU) 和Th17细胞功能中的作用.
评估TIGIT刺激对Treg产生的影响和阿联的治疗疗效.

主要方法:

检查了Th17和Treg细胞上的TIGIT表达.
使用实验性自身免疫性脑膜炎的小鼠模型.
在临床症状出现时服用TIGIT激动剂.
评估了疾病的严重程度,眼部免疫细胞的透和Treg介导的抑制.

主要成果:

TIGIT刺激显著降低了实验性自身免疫性脑膜炎的严重程度.
在TIGIT激动剂治疗后,致病性Th17细胞的眼内透被抑制.
从TIGIT治疗的小鼠生成的Tregs在接受者小鼠中表现出抑制能力,从而赋予了对EAU的耐药性.

结论:

在疾病发作时的TIGIT刺激有效地抑制了眼部自身免疫性疾病的症状.
激活TIGIT诱导调节性T细胞免疫,提供对实验性自身免疫性脑膜炎的抵抗力.
TIGIT激动剂代表了眼睛自身免疫性疾病的有前途的治疗策略.

关键词:

在TIGIT+ Tregs中使用.自身免疫性脑膜炎的发生眼部免疫特权眼部免疫特权 th17 细胞细胞

更多相关视频

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.